Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 110 articles:
HTML format



Single Articles


    August 2021
  1. ASHIZAWA N, Shimizu H, Shoda K, Furuya S, et al
    NADPH oxidase 5 has a crucial role in cellular motility of colon cancer cells.
    Int J Oncol. 2021;59.
    PubMed     Abstract available


    July 2021
  2. SHEN X, Ye Z, Wu W, Zhao K, et al
    lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
    Int J Oncol. 2021;59.
    PubMed     Abstract available


    June 2021
  3. YANG Q, Wang X, Tang C, Chen X, et al
    [Retracted] H19 promotes the migration and invasion of colon cancer by sponging miR138 to upregulate the expression of HMGA1.
    Int J Oncol. 2021;58.
    PubMed     Abstract available


  4. LIAO Z, Zhang H, Fan P, Huang Q, et al
    [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
    Int J Oncol. 2021;58.
    PubMed     Abstract available


    May 2021
  5. ABDULLA MH, Agarwal D, Singh JK, Traiki TB, et al
    Association of the microbiome with colorectal cancer development (Review).
    Int J Oncol. 2021;58.
    PubMed     Abstract available


    December 2020
  6. OH S, Song H, Freeman WM, Shin S, et al
    Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
    Int J Oncol. 2020;57:1319-1332.
    PubMed     Abstract available


  7. PARK M, Kwon J, Shin HJ, Moon SM, et al
    Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patientderived organoids.
    Int J Oncol. 2020;57:1307-1318.
    PubMed     Abstract available


    November 2020
  8. WANG J, Liang D, Zhang XP, He CF, et al
    Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy.
    Int J Oncol. 2020 Nov 23. doi: 10.3892/ijo.2020.5151.
    PubMed     Abstract available


    September 2020
  9. QIAN J, Garg A, Li F, Shen Q, et al
    lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR4953p/MYCBP axis.
    Int J Oncol. 2020 Sep 25. doi: 10.3892/ijo.2020.5128.
    PubMed     Abstract available


  10. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    PubMed     Abstract available


  11. KOYAMA M, Kitazawa M, Nakamura S, Matsumura T, et al
    Lowdose trametinib and BclxL antagonist have a specific antitumor effect in KRASmutated colorectal cancer cells.
    Int J Oncol. 2020 Sep 2. doi: 10.3892/ijo.2020.5117.
    PubMed     Abstract available


    August 2020
  12. KIM SL, La MT, Shin MW, Kim SW, et al
    A novel HDAC1 inhibitor, CBUD1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells.
    Int J Oncol. 2020 Aug 10. doi: 10.3892/ijo.2020.5109.
    PubMed     Abstract available


    May 2020
  13. KITSOU M, Ayiomamitis GD, Zaravinos A
    High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
    Int J Oncol. 2020 May 8. doi: 10.3892/ijo.2020.5062.
    PubMed     Abstract available


    April 2020
  14. JIANG F, Chen Y, Ren S, Li Z, et al
    Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1AKT/ERKSnail signaling pathway.
    Int J Oncol. 2020 Apr 3. doi: 10.3892/ijo.2020.5038.
    PubMed     Abstract available


    March 2020
  15. ACKERMANN A, Lafferton B, Plotz G, Zeuzem S, et al
    Expression and secretion of the proinflammatory cytokine IL8 is increased in colorectal cancer cells following the knockdown of nonerythroid spectrin alphaII.
    Int J Oncol. 2020 Mar 26. doi: 10.3892/ijo.2020.5026.
    PubMed     Abstract available


  16. YANG Z, Chen Y, Wei X, Wu D, et al
    Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Int J Oncol. 2020 Mar 26. doi: 10.3892/ijo.2020.5027.
    PubMed     Abstract available


  17. YE Y, Jiang D, Li J, Han C, et al
    Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer.
    Int J Oncol. 2020 Mar 26. doi: 10.3892/ijo.2020.5029.
    PubMed     Abstract available


  18. KUMAMOTO T, Yamada K, Yoshida S, Aoki K, et al
    Impairment of DYRK2 by DNMT1mediated transcription augments carcinogenesis in human colorectal cancer.
    Int J Oncol. 2020 Mar 20. doi: 10.3892/ijo.2020.5020.
    PubMed     Abstract available


  19. TANG W, Hong L, Dai W, Li J, et al
    MicroRNA500a5p inhibits colorectal cancer cell invasion and epithelialmesenchymal transition.
    Int J Oncol. 2020 Mar 19. doi: 10.3892/ijo.2020.5015.
    PubMed     Abstract available


  20. COLLARD TJ, Fallatah HM, Greenhough A, Paraskeva C, et al
    BCL3 promotes cyclooxygenase2/prostaglandin E2 signalling in colorectal cancer.
    Int J Oncol. 2020 Mar 16. doi: 10.3892/ijo.2020.5013.
    PubMed     Abstract available


  21. CHO WC, Jang JE, Kim KH, Yoo BC, et al
    SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines.
    Int J Oncol. 2020 Mar 5. doi: 10.3892/ijo.2020.5006.
    PubMed     Abstract available


  22. KIM B, Seo JH, Lee KY, Park B, et al
    Icariin sensitizes human colon cancer cells to TRAILinduced apoptosis via ERKmediated upregulation of death receptors.
    Int J Oncol. 2020;56:821-834.
    PubMed     Abstract available


    December 2019
  23. HU SM, Yao XH, Hao YH, Pan AH, et al
    8Gingerol regulates colorectal cancer cell proliferation and migration through the EGFR/STAT/ERK pathway.
    Int J Oncol. 2019 Dec 3. doi: 10.3892/ijo.2019.4934.
    PubMed     Abstract available


  24. YOKOYAMA Y, Sakatani T, Wada R, Ishino K, et al
    In vitro and in vivo studies on the association of long noncoding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5fluorouracil in rectal cancer.
    Int J Oncol. 2019;55:1361-1371.
    PubMed     Abstract available


    August 2019
  25. AN HJ, Park M, Kim J, Han YH, et al
    miR5191 functions as a tumor suppressor by targeting RPS6KB1 in colorectal cancer.
    Int J Oncol. 2019 Aug 30. doi: 10.3892/ijo.2019.4865.
    PubMed     Abstract available


  26. FRICKE F, Mussack V, Buschmann D, Hausser I, et al
    TGFBR2dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells.
    Int J Oncol. 2019 Aug 19. doi: 10.3892/ijo.2019.4859.
    PubMed     Abstract available


  27. YUSUFU A, Shayimu P, Tuerdi R, Fang C, et al
    TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process.
    Int J Oncol. 2019 Aug 5. doi: 10.3892/ijo.2019.4854.
    PubMed     Abstract available


    July 2019
  28. WU F, Xing T, Gao X, Liu F, et al
    miR5013p promotes colorectal cancer progression via activation of Wnt/betacatenin signaling.
    Int J Oncol. 2019 Jul 30. doi: 10.3892/ijo.2019.4852.
    PubMed     Abstract available


  29. CHU X, Xue Y, Huo X, Wei J, et al
    Establishment and characterization of a novel cell line (cc006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient.
    Int J Oncol. 2019;55:243-256.
    PubMed     Abstract available


    June 2019
  30. YANG W, Shi J, Zhou Y, Liu T, et al
    Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Int J Oncol. 2019 Jun 27. doi: 10.3892/ijo.2019.4833.
    PubMed     Abstract available


  31. PARK YL, Kim SH, Park SY, Jung MW, et al
    Forkheadbox A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
    Int J Oncol. 2019;54:2169-2178.
    PubMed     Abstract available


  32. OHKUBO S, Mancinelli R, Miglietta S, Cona A, et al
    Maize polyamine oxidase in the presence of spermine/spermidine induces the apoptosis of LoVo human colon adenocarcinoma cells.
    Int J Oncol. 2019;54:2080-2094.
    PubMed     Abstract available


  33. MOON JR, Oh SJ, Lee CK, Chi SG, et al
    TGF-beta1 protects colon tumor cells from apoptosis through XAF1 suppression.
    Int J Oncol. 2019;54:2117-2126.
    PubMed     Abstract available


    May 2019
  34. OLEJNICZAK-KEDER A, Szarynska M, Wronska A, Siedlecka-Kroplewska K, et al
    Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines.
    Int J Oncol. 2019 May 23. doi: 10.3892/ijo.2019.4809.
    PubMed     Abstract available


  35. XING Y, Ren S, Ai L, Sun W, et al
    ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway.
    Int J Oncol. 2019;54:1691-1703.
    PubMed     Abstract available


    April 2019
  36. BASHIR AIJ, Kankipati CS, Jones S, Newman RM, et al
    A novel mechanism for the anticancer activity of aspirin and salicylates.
    Int J Oncol. 2019;54:1256-1270.
    PubMed     Abstract available


  37. OUYANG M, Luo Z, Zhang W, Zhu D, et al
    Protective effect of curcumin against irinotecaninduced intestinal mucosal injury via attenuation of NFkappaB activation, oxidative stress and endoplasmic reticulum stress.
    Int J Oncol. 2019;54:1376-1386.
    PubMed     Abstract available


    March 2019
  38. CAI Z, Wang L, Han Y, Gao W, et al
    Immunoglobulinlike transcript 4 and human leukocyte antigenG interaction promotes the progression of human colorectal cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4761.
    PubMed     Abstract available


  39. SUN J, Feng Y, Wang Y, Ji Q, et al
    alpha-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation.
    Int J Oncol. 2019 Mar 19. doi: 10.3892/ijo.2019.4757.
    PubMed     Abstract available


  40. KIM SL, Min IS, Park YR, Lee ST, et al
    [Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPKmediated DR5 regulation in colorectal cancer.
    Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4748.
    PubMed     Abstract available


  41. PARK YL, Ha SY, Park SY, Choi JH, et al
    Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
    Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4746.
    PubMed     Abstract available


    February 2019
  42. BAO Y, Lu Y, Feng W, Yu H, et al
    COUPTFII promotes epithelialmesenchymal transition by inhibiting miR34a expression in colorectal cancer.
    Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4718.
    PubMed     Abstract available


  43. LIAO Z, Zhang H, Fan P, Huang Q, et al
    High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
    Int J Oncol. 2019;54:479-490.
    PubMed     Abstract available


  44. CHIBAUDEL B, Bachet JB, Andre T, Auby D, et al
    Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as firstline therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
    Int J Oncol. 2019 Feb 1. doi: 10.3892/ijo.2019.4709.
    PubMed     Abstract available


    January 2019
  45. YAMAGUCHI M, Hankinson O
    2,3,7,8tetrachlorodibenzopdioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.
    Int J Oncol. 2019 Jan 30. doi: 10.3892/ijo.2019.4703.
    PubMed     Abstract available


  46. TANG L, Zhao P, Kong D
    Muscleblindlike 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail/Ecadherin axis.
    Int J Oncol. 2019 Jan 18. doi: 10.3892/ijo.2019.4691.
    PubMed     Abstract available


  47. ZHAO H, Yan C, Hu Y, Mu L, et al
    Sphereforming assay vs. organoid culture: Determining longterm stemness and the chemoresistant capacity of primary colorectal cancer cells.
    Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4683.
    PubMed     Abstract available


  48. HOKONOHARA K, Nishida N, Miyoshi N, Takahashi H, et al
    Involvement of MAF1 homolog, negative regulator of RNA polymerase III in colorectal cancer progression.
    Int J Oncol. 2019 Jan 7. doi: 10.3892/ijo.2019.4678.
    PubMed     Abstract available


    December 2018
  49. CHENG Y, Lu Y, Zhang D, Lian S, et al
    Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and metabolic reprogramming.
    Int J Oncol. 2018;53:2590-2604.
    PubMed     Abstract available


    November 2018
  50. LE DT, Jung S, Quynh NTN, Sandag Z, et al
    Inhibitory role of AMPactivated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation.
    Int J Oncol. 2018 Nov 14. doi: 10.3892/ijo.2018.4634.
    PubMed     Abstract available


  51. WANG ZZ, Yang J, Jiang BH, Di JB, et al
    KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
    Int J Oncol. 2018;53:1939-1952.
    PubMed     Abstract available


  52. QIAN W, Zhang Z, Peng W, Li J, et al
    CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
    Int J Oncol. 2018;53:2021-2033.
    PubMed     Abstract available


  53. LEI X, Deng L, Liu D, Liao S, et al
    ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells.
    Int J Oncol. 2018;53:1980-1996.
    PubMed     Abstract available


    October 2018
  54. LIU SQ, Xu CY, Wu WH, Fu ZH, et al
    Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelialmesenchymal transition mediated by the FAK/AKT/MMPs axis.
    Int J Oncol. 2018 Oct 25. doi: 10.3892/ijo.2018.4607.
    PubMed     Abstract available


  55. LIU L, Liu H, Zhou Y, He J, et al
    HLTF suppresses the migration and invasion of colorectal cancer cells via TGFbeta/SMAD signaling in vitro.
    Int J Oncol. 2018 Oct 10. doi: 10.3892/ijo.2018.4591.
    PubMed     Abstract available


  56. WANG Y, Yang L, Zhang J, Zhou M, et al
    Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Int J Oncol. 2018;53:1667-1680.
    PubMed     Abstract available


  57. PAREDES J, Ji P, Lacomb JF, Shroyer KR, et al
    Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity.
    Int J Oncol. 2018;53:1516-1528.
    PubMed     Abstract available


  58. SCHROTEROVA L, Jezkova A, Rudolf E, Caltova K, et al
    Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro.
    Int J Oncol. 2018;53:1625-1632.
    PubMed     Abstract available


    September 2018
  59. TURANO M, Costabile V, Cerasuolo A, Duraturo F, et al
    Characterisation of mesenchymal colon tumour-derived cells in tumourspheres as a model for colorectal cancer progression.
    Int J Oncol. 2018 Sep 18. doi: 10.3892/ijo.2018.4565.
    PubMed     Abstract available


  60. KIM SL, Min IS, Park YR, Lee ST, et al
    Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Int J Oncol. 2018 Sep 14. doi: 10.3892/ijo.2018.4562.
    PubMed     Abstract available


    August 2018
  61. ZHANG Z, Fang C, Wang Y, Zhang J, et al
    COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.
    Int J Oncol. 2018 Aug 22. doi: 10.3892/ijo.2018.4536.
    PubMed     Abstract available


  62. LIU RX, Ma Y, Hu XL, Ren WY, et al
    Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
    Int J Oncol. 2018 Aug 16. doi: 10.3892/ijo.2018.4527.
    PubMed     Abstract available


  63. WANG Z, Zhao X, Wang W, Liu Y, et al
    ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NFkappaB signaling pathway.
    Int J Oncol. 2018 Aug 10. doi: 10.3892/ijo.2018.4521.
    PubMed     Abstract available


  64. LUCAS J, Hsieh TC, Halicka HD, Darzynkiewicz Z, et al
    Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFkappaB signaling.
    Int J Oncol. 2018 Aug 1. doi: 10.3892/ijo.2018.4512.
    PubMed     Abstract available


    July 2018
  65. ZHOU L, Zhan ML, Tang Y, Xiao M, et al
    Effects of beta-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
    Int J Oncol. 2018 Jul 27. doi: 10.3892/ijo.2018.4506.
    PubMed     Abstract available


  66. KWAK B, Kim DU, Kim TO, Kim HS, et al
    MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Int J Oncol. 2018 Jul 26. doi: 10.3892/ijo.2018.4505.
    PubMed     Abstract available


  67. HUANG M, Geng Y, Deng Q, Li R, et al
    Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4502.
    PubMed     Abstract available


  68. CARRIERE PP, Kapur N, Mir H, Ward AB, et al
    Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.
    Int J Oncol. 2018 Jul 19. doi: 10.3892/ijo.2018.4489.
    PubMed     Abstract available


  69. ZHANG H, Yang W, Yan J, Zhou K, et al
    Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Int J Oncol. 2018 Jul 9. doi: 10.3892/ijo.2018.4475.
    PubMed     Abstract available


  70. ZHOU ZP, Wang LP, Hong ZS, Qiu CZ, et al
    Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Int J Oncol. 2018 Jul 5. doi: 10.3892/ijo.2018.4471.
    PubMed     Abstract available


  71. LIU M, Zhao G, Zhang D, An W, et al
    Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells.
    Int J Oncol. 2018 Jul 2. doi: 10.3892/ijo.2018.4465.
    PubMed     Abstract available


    June 2018
  72. SU P, Yang Y, Wang G, Chen X, et al
    Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Int J Oncol. 2018 Jun 29. doi: 10.3892/ijo.2018.4461.
    PubMed     Abstract available


  73. YAMAGUCHI M, Osuka S, Murata T
    Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
    Int J Oncol. 2018 Jun 28. doi: 10.3892/ijo.2018.4458.
    PubMed     Abstract available


  74. LEE SR, Jin H, Kim WT, Kim WJ, et al
    Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
    Int J Oncol. 2018 Jun 25. doi: 10.3892/ijo.2018.4453.
    PubMed     Abstract available


  75. CHEN ZP, Wei JC, Wang Q, Yang P, et al
    Long noncoding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA206 in colorectal cancer.
    Int J Oncol. 2018 Jun 22. doi: 10.3892/ijo.2018.4451.
    PubMed     Abstract available


  76. WANG B, Yin M, Cheng C, Jiang H, et al
    Decreased expression of miR4903p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4444.
    PubMed     Abstract available


  77. QIAN K, Huang H, Jiang J, Xu D, et al
    Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNAceRNA interaction network in colorectal cancer.
    Int J Oncol. 2018 Jun 18. doi: 10.3892/ijo.2018.4443.
    PubMed     Abstract available


  78. CHEN J, Gong C, Mao H, Li Z, et al
    E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Int J Oncol. 2018 Jun 5. doi: 10.3892/ijo.2018.4429.
    PubMed     Abstract available


  79. MORTENSEN AC, Spiegelberg D, Haylock AK, Lundqvist H, et al
    Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
    Int J Oncol. 2018;52:1875-1885.
    PubMed     Abstract available


  80. CHOWCHAIKONG N, Nilwarangkoon S, Laphookhieo S, Tanunyutthawongse C, et al
    p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells.
    Int J Oncol. 2018;52:2031-2040.
    PubMed     Abstract available


    May 2018
  81. JIANG J, Liu HL, Tao L, Lin XY, et al
    Let7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
    Int J Oncol. 2018 May 23. doi: 10.3892/ijo.2018.4419.
    PubMed     Abstract available


  82. ZHANG Y, Feng Y, Ji D, Wang Q, et al
    TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4408.
    PubMed     Abstract available


  83. LEE DH, Won HR, Ryu HW, Han JM, et al
    The HDAC6 inhibitor ACY1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4405.
    PubMed     Abstract available


  84. SU MQ, Zhou YR, Rao X, Yang H, et al
    Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4402.
    PubMed     Abstract available


  85. LI X, Zhao X, Yang B, Li Y, et al
    Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.
    Int J Oncol. 2018 May 9. doi: 10.3892/ijo.2018.4400.
    PubMed     Abstract available


    April 2018
  86. PARK BK, Park JY, Kim TH, Kim D, et al
    Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
    Int J Oncol. 2018 Apr 26. doi: 10.3892/ijo.2018.4385.
    PubMed     Abstract available


  87. WU S, Wu F, Jiang Z
    Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Int J Oncol. 2018 Apr 2. doi: 10.3892/ijo.2018.4352.
    PubMed     Abstract available


  88. TOMIDA C, Yamagishi N, Nagano H, Uchida T, et al
    VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
    Int J Oncol. 2018;52:1350-1362.
    PubMed     Abstract available


    March 2018
  89. XIE Y, Liu Y, Li Q, Chen J, et al
    Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4328.
    PubMed     Abstract available


  90. JIN L, Si Y, Hong X, Liu P, et al
    Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4323.
    PubMed     Abstract available


  91. MATSUHASHI N, Takahashi T, Matsui S, Tanahashi T, et al
    A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4322.
    PubMed     Abstract available


  92. MAEDA Y, Takahashi H, Nakai N, Yanagita T, et al
    Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer.
    Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4308.
    PubMed     Abstract available


  93. SU C, Li D, Li N, Du Y, et al
    Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.
    Int J Oncol. 2018 Mar 6. doi: 10.3892/ijo.2018.4305.
    PubMed     Abstract available


  94. LI N, Mao D, Cao Y, Li H, et al
    Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4304.
    PubMed     Abstract available


    February 2018
  95. HE P, Li K, Li SB, Hu TT, et al
    Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.
    Int J Oncol. 2018 Feb 23. doi: 10.3892/ijo.2018.4284.
    PubMed     Abstract available


  96. BAI B, Xie B, Pan Z, Shan L, et al
    Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer.
    Int J Oncol. 2018 Feb 22. doi: 10.3892/ijo.2018.4281.
    PubMed     Abstract available


  97. FORSTER S, Hehlgans S, Rodel F, Otto B, et al
    Differential effects of alpha-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells.
    Int J Oncol. 2018 Feb 21. doi: 10.3892/ijo.2018.4279.
    PubMed     Abstract available


  98. NISHIZAWA Y, Konno M, Asai A, Koseki J, et al
    Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer.
    Int J Oncol. 2018;52:453-460.
    PubMed     Abstract available


  99. CHEN J, Lou Q, He L, Wen C, et al
    Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells.
    Int J Oncol. 2018 Feb 1. doi: 10.3892/ijo.2018.4264.
    PubMed     Abstract available


    January 2018
  100. NAGATA H, Ishihara S, Kishikawa J, Sonoda H, et al
    CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4240.
    PubMed     Abstract available


  101. LEE JY, Kim MS, Ju JE, Lee MS, et al
    Simvastatin enhances the radiosensitivity of p53deficient cells via inhibition of mouse double minute 2 homolog.
    Int J Oncol. 2018;52:211-218.
    PubMed     Abstract available


    November 2017
  102. OLEJNICZAK A, Szarynska M, Kmiec Z
    In vitro characterization of spheres derived from colorectal cancer cell lines.
    Int J Oncol. 2017 Nov 16. doi: 10.3892/ijo.2017.4206.
    PubMed     Abstract available


  103. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    PubMed     Abstract available


  104. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    PubMed     Abstract available


    October 2017
  105. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    PubMed     Abstract available


  106. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    PubMed     Abstract available


  107. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    PubMed     Abstract available


  108. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    PubMed     Abstract available


  109. LEE YJ, Kang YR, Lee SY, Jin Y, et al
    Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of bMyb and miRNA34a expression.
    Int J Oncol. 2017;51:1331-1342.
    PubMed     Abstract available


    September 2017
  110. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: